- Home
- CLIR vs ANTX Comparison
CLIR vs ANTX Comparison
Compare CLIR & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLIR
- ANTX
- Stock Information
- Founded
- CLIR 2008
- ANTX 2017
- Country
- CLIR United States
- ANTX United States
- Employees
- CLIR N/A
- ANTX N/A
- Industry
- CLIR Industrial Machinery/Components
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- CLIR Industrials
- ANTX Health Care
- Exchange
- CLIR Nasdaq
- ANTX Nasdaq
- Market Cap
- CLIR 31.2M
- ANTX 31.7M
- IPO Year
- CLIR 2012
- ANTX 2022
- Fundamental
- Price
- CLIR $0.57
- ANTX $1.13
- Analyst Decision
- CLIR Strong Buy
- ANTX Buy
- Analyst Count
- CLIR 1
- ANTX 2
- Target Price
- CLIR $2.00
- ANTX $2.00
- AVG Volume (30 Days)
- CLIR 77.9K
- ANTX 74.2K
- Earning Date
- CLIR 08-14-2025
- ANTX 08-12-2025
- Dividend Yield
- CLIR N/A
- ANTX N/A
- EPS Growth
- CLIR N/A
- ANTX N/A
- EPS
- CLIR N/A
- ANTX N/A
- Revenue
- CLIR $2,983,000.00
- ANTX N/A
- Revenue This Year
- CLIR $27.61
- ANTX N/A
- Revenue Next Year
- CLIR $116.19
- ANTX N/A
- P/E Ratio
- CLIR N/A
- ANTX N/A
- Revenue Growth
- CLIR 19.03
- ANTX N/A
- 52 Week Low
- CLIR $0.46
- ANTX $0.95
- 52 Week High
- CLIR $1.72
- ANTX $1.68
- Technical
- Relative Strength Index (RSI)
- CLIR 51.26
- ANTX 48.76
- Support Level
- CLIR $0.56
- ANTX $1.03
- Resistance Level
- CLIR $0.62
- ANTX $1.10
- Average True Range (ATR)
- CLIR 0.04
- ANTX 0.03
- MACD
- CLIR 0.00
- ANTX -0.00
- Stochastic Oscillator
- CLIR 59.77
- ANTX 53.33
About CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.